{"gene":"SP1","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":1988,"finding":"Sp1 contains distinct regions for DNA binding and transcriptional activation: Zn(II) fingers confer sequence-specific DNA binding, a separate region regulates DNA-binding affinity, and at least two distinct segments contribute to transcriptional activation of RNA polymerase II in vitro.","method":"Deletion mutagenesis, E. coli expression of Sp1 fragments, in vitro transcription assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, foundational study replicated across subsequent work","pmids":["3059495"],"is_preprint":false},{"year":1991,"finding":"Sp1 forms tetramers and assembles multiple stacked tetramers at DNA loop junctures, mediating long-range transcriptional synergism between distal and proximal GC box elements via DNA looping.","method":"Conventional and scanning transmission electron microscopy of Sp1-DNA complexes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct structural visualization by two EM modalities with functional context","pmids":["2062845"],"is_preprint":false},{"year":1992,"finding":"Retinoblastoma protein (Rb) positively regulates Sp1 transcriptional activity; using a GAL4-Sp1 fusion protein, Rb was shown to directly stimulate Sp1-mediated transactivation in vivo.","method":"GAL4-Sp1 fusion co-transfection, reporter gene assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay with fusion protein, single lab, corroborated by PMID:8007947","pmids":["1588949"],"is_preprint":false},{"year":1994,"finding":"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for common GC-box DNA binding sites; chimeric protein analysis showed that neither the glutamine-rich A/B domains nor the D domain of Sp1 can be functionally replaced by the homologous Sp3 regions.","method":"Co-transfection reporter assays in mammalian cells and Sp-factor-deficient Drosophila SL2 cells, antibody generation, chimeric protein expression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (competition assay, chimeric proteins, SL2 cell reconstitution), replicated across cell lines","pmids":["8070411"],"is_preprint":false},{"year":1994,"finding":"Rb stimulates Sp1-mediated transactivation by liberating Sp1 from a ~20 kDa negative regulator protein (Sp1-I); recombinant Rb reversed Sp1-I-mediated inhibition of Sp1 DNA binding, and Sp1-I was identified as an RB-associated protein.","method":"Mobility shift assay, antibody supershift, recombinant protein addition, co-transfection with GAL4-Sp1, identification of Sp1-I by biochemical fractionation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (EMSA, co-transfection, biochemical fractionation), single lab","pmids":["8007947"],"is_preprint":false},{"year":1995,"finding":"Stat1 and Sp1 physically interact (co-immunoprecipitation from primary cells without overexpression) and both must occupy contiguous DNA binding sites for full interferon-gamma-dependent activation of the ICAM-1 gene, demonstrating transcriptional synergy.","method":"Co-immunoprecipitation, DNA/protein binding assay (EMSA), transfected reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP from primary cells, multiple orthogonal methods, functional epistasis confirmed","pmids":["8530443"],"is_preprint":false},{"year":1997,"finding":"cAMP-dependent protein kinase (PKA) activates Sp1 transcriptional and DNA-binding activity; recombinant Sp1 DNA-binding activity is stimulated by exogenous PKA in vitro, and PKA antagonists inhibit Sp1-dependent reporter activity.","method":"In vitro kinase assay with recombinant Sp1, insect-cell co-transfection reporter assay, PKA agonist/antagonist pharmacology","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution with recombinant proteins plus cell-based validation, single lab","pmids":["9261118"],"is_preprint":false},{"year":1998,"finding":"Rb physically associates with Sp1 in nuclear complexes across all cell cycle phases (reciprocal co-immunoprecipitation and supershift), and this association potentiates Sp1-mediated transcription of the DHFR promoter through its GC box.","method":"Co-immunoprecipitation, EMSA supershift, immunodepletion, co-transfection reporter assay with GC-box point mutant","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, EMSA supershift, functional mutagenesis, single lab with multiple orthogonal methods","pmids":["9591776"],"is_preprint":false},{"year":1999,"finding":"ERK2 phosphorylates Sp1 and stimulates its DNA-binding activity; pretreatment of cell extracts with recombinant ERK2 increased Sp1 binding, while dephosphorylation reduced it. The Ras-ERK cascade mediates EGF-inducible gastrin promoter activation through Sp1.","method":"In vitro phosphorylation with recombinant ERK2, EMSA, dephosphorylation assay, co-transfection with dominant-negative/active constructs, MEK inhibitor (PD98059)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus cell-based epistasis, single lab","pmids":["9918860"],"is_preprint":false},{"year":2000,"finding":"ERα and ERβ physically interact with Sp1 (co-immunoprecipitation) and preferentially bind the C-terminal region of Sp1 (pull-down assay); the AF-1 domain (amino acids 79–117) of ERα is required for transcriptional activation at GC-rich Sp1 promoter elements.","method":"Co-immunoprecipitation, pull-down assay, chimeric ER expression, transactivation reporter assay, AF-1 deletion analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, pull-down, chimeric protein mapping, multiple cell lines","pmids":["10681512"],"is_preprint":false},{"year":2001,"finding":"Cyclin A-CDK complexes physically interact with Sp1 (co-immunoprecipitation) and phosphorylate it in vitro and in vivo at an N-terminal site; this phosphorylation augments Sp1 DNA-binding activity and transcriptional activation. Mutation of the phosphorylation site abolished cyclin A-CDK-dependent effects.","method":"Co-immunoprecipitation, in vitro and in vivo phosphorylation assay, DNA binding site selection/PCR, co-transfection reporter assay, phosphorylation-site mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay, mutagenesis, co-IP, functional reporter assay, multiple orthogonal methods","pmids":["11598016"],"is_preprint":false},{"year":2002,"finding":"LPS dephosphorylates Sp1 at serine and threonine residues (but not tyrosine) in vivo and promotes Sp1 protein degradation, both of which reduce Sp1 DNA-binding activity and decrease expression of Sp1-dependent target genes (eNOS, COX-1).","method":"EMSA, immunoprecipitation-Western blot, in vitro dephosphorylation, nuclear fractionation, RT-PCR, in vivo mouse lung model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in vivo and in vitro, single lab","pmids":["12089157"],"is_preprint":false},{"year":2007,"finding":"Sp1 undergoes phosphorylation-driven proteolytic processing, desumoylation, and degradation: Ser59 regulates N-terminal cleavage; Lys16 is the SUMO-1/ubiquitin target; Ser7 enhances ubiquitination; PKCα and the PKC-ERK-ERBB2 axis drive Sp1 processing. CyclinA/CDK2 phosphorylation of Ser59 relieves SUMO-mediated repression.","method":"In vitro sumoylation/ubiquitination assays, site-directed mutagenesis, kinase inhibitor studies, pulse-chase, co-transfection","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays and mutagenesis, single lab","pmids":["18239466"],"is_preprint":false},{"year":2008,"finding":"O-GlcNAc modification within the second serine/threonine-rich region of Sp1 inhibits the physical interaction between Sp1 and Oct1, thereby suppressing cooperative activation of the U2 snRNA gene.","method":"Co-immunoprecipitation, O-GlcNAc site mapping, transcriptional reporter assay, site-directed mutagenesis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical interaction and functional reporter with mutagenesis, single lab","pmids":["19070619"],"is_preprint":false},{"year":2009,"finding":"Hsp90 interacts with Sp1 during mitosis and maintains Sp1 stability via JNK1-mediated phosphorylation at Thr278 and Thr739; inhibition or knockdown of Hsp90 decreases JNK1 activity and leads to ubiquitin-dependent proteasomal degradation of Sp1 during mitosis.","method":"Co-immunoprecipitation, geldanamycin treatment, shRNA knockdown, site-directed mutagenesis of JNK1 phosphorylation sites, ubiquitination assay","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, mutagenesis, and knockdown with functional readout, single lab","pmids":["19245816"],"is_preprint":false},{"year":2011,"finding":"RNF4 is the ubiquitin E3 ligase for Sp1: sumoylated Sp1 (at Lys16) recruits RNF4, leading to proteasomal degradation. JNK1-mediated phosphorylation of Sp1 at Thr739 during mitosis abolishes the Sp1-RNF4 interaction, protecting Sp1 from degradation and maintaining its levels for cell division.","method":"In vitro and in vivo ubiquitination assays, co-immunoprecipitation, site-directed mutagenesis (Lys16, Thr739), domain mapping, proteasome inhibitor","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution, mutagenesis of key sites, co-IP, multiple orthogonal methods in single study","pmids":["21983342"],"is_preprint":false},{"year":2014,"finding":"Pin1 is recruited to the phospho-Thr739-Pro motif of Sp1 and facilitates CDK1-mediated phosphorylation at Ser720, Thr723, and Thr737 during mitosis; X-ray crystallography confirmed Pin1 binding to the pThr739 peptide. Increased CDK1 phosphorylation stabilizes Sp1 (via reduced RNF4 interaction) and displaces it from chromosomes, facilitating cell cycle progression.","method":"Isothermal titration calorimetry, X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation, in vitro phosphorylation, ChIP, cell cycle analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of Pin1-pSp1 peptide complex, ITC binding quantification, mutagenesis, multiple orthogonal methods","pmids":["25398907"],"is_preprint":false},{"year":2014,"finding":"SUMO2 negatively regulates Sp1 by: (1) sumoylating Sp1 at Lys683 to attenuate DNA binding; (2) sumoylating Sp1 at Lys16 to increase its turnover; and (3) interfering with the Sp1-p300 coactivator interaction and recruiting Sp3 repressor. SUMO1 positively regulates Sp1 and forms complexes with it; these differential SUMO modifications control lens cell differentiation.","method":"Co-immunoprecipitation, in vivo and in vitro sumoylation assays, site-directed mutagenesis (K683, K16), EMSA, ChIP, reporter assays, SUMO1/2/3 knockdown/overexpression, Lgr5-KI reporter mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple sumoylation site mutants, in vitro and in vivo assays, animal model, multiple orthogonal methods","pmids":["24706897"],"is_preprint":false},{"year":2018,"finding":"Caspase cleavage of Sp1 at Asp183 (identified in vitro) produces a 70 kDa C-terminal fragment (Sp1-70C, aa 184–785); the Sp1-D183A mutant is resistant to cleavage and renders cells resistant to apoptotic stimuli, whereas Sp1-70C overexpression induces apoptosis, demonstrating that caspase cleavage of Sp1 promotes apoptosis.","method":"In vitro caspase cleavage assay, site-directed mutagenesis (D183A), ectopic expression of cleavage-resistant and truncated Sp1 forms, apoptosis assays (DNA damage, TRAIL)","journal":"Apoptosis","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro cleavage with mutagenesis, functional gain/loss-of-function with defined phenotypic readout, multiple stimuli","pmids":["29236199"],"is_preprint":false},{"year":2019,"finding":"SIRT6 binds directly to the zinc finger DNA-binding domain of Sp1 and represses its transcriptional activity, independent of SIRT6 deacetylase activity; SIRT6 deficiency increases Sp1 occupancy at mTOR signaling gene promoters, activating mTOR and increasing global protein synthesis.","method":"Co-immunoprecipitation, domain-mapping pull-down, ChIP, reporter assays, mTOR inhibitor rescue, muscle-specific SIRT6 knockout mice, pharmacological inhibition","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-mapping co-IP, ChIP, genetic KO model, pharmacological rescue, multiple orthogonal methods","pmids":["31372634"],"is_preprint":false},{"year":2021,"finding":"ATM phosphorylation of Sp1 (at Ser101) in response to DNA damage triggers its sumoylation at Lys16 and subsequent RNF4-mediated proteasomal degradation, driving cellular senescence; Sp1 phospho-null (S101A) or sumo-null (K16R) mutants resist degradation and reduce senescence markers.","method":"Site-directed mutagenesis (S101A, K16R), ATM inhibitor, proteasome inhibitor, sumoylation assay, senescence marker analysis (SA-β-gal, p21, p16)","journal":"GeroScience","confidence":"High","confidence_rationale":"Tier 2 / Strong — phospho-null and sumo-null mutagenesis with defined phenotypic readout, genetic and pharmacological epistasis, single lab but multiple orthogonal approaches","pmids":["34550526"],"is_preprint":false},{"year":2021,"finding":"USP39 deubiquitinates and stabilizes SP1 protein, prolonging its half-life; SP1 is identified as a substrate of USP39, and knockdown of USP39 promotes SP1 degradation, with SP1 overexpression reversing USP39-knockdown-induced apoptosis and cell cycle arrest.","method":"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase (half-life measurement), siRNA knockdown/rescue, in vivo xenograft","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, biochemical deubiquitination evidence, functional rescue, single lab","pmids":["34197957"],"is_preprint":false},{"year":2021,"finding":"ZRANB1 directly binds SP1 and stabilizes it through deubiquitination; ZRANB1-SP1 axis regulates LOXL2 transcription to promote HCC growth and metastasis.","method":"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function studies, RNA-seq, xenograft","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding shown by co-IP, biochemical deubiquitination, functional rescue, single lab","pmids":["34765294"],"is_preprint":false},{"year":2021,"finding":"TRRAP is required for SP1 binding at promoters of microtubule dynamics genes in Purkinje neurons; TRRAP loss reduces SP1 chromatin occupancy and disrupts a conserved SP1-dependent transcriptional program, with ectopic expression of Stathmin3/4 rescuing TRRAP-deficient neuronal defects.","method":"Integrated transcriptomics, epigenomics (ChIP-seq), proteomics, conditional Trrap knockout mice, ectopic gene expression rescue","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq in KO model, multi-omics, genetic rescue, multiple orthogonal approaches","pmids":["33594975"],"is_preprint":false},{"year":2021,"finding":"Sp1 is a substrate of Keap1: Sp1 physically interacts with Keap1, which promotes Sp1 ubiquitination. Sp1 in turn regulates CUL4A expression by binding its promoter, and SP1 regulates Nrf2 protein levels via the CRL4AWDR23 ubiquitin ligase complex.","method":"Co-immunoprecipitation, ubiquitination assay, ChIP, siRNA knockdown, reporter assays, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, biochemical ubiquitination, ChIP, multiple knockdown experiments, single lab","pmids":["33895141"],"is_preprint":false},{"year":2014,"finding":"Sp1 binds to the miR-200b~200a~429 proximal promoter and activates miR-200 family expression in epithelial cells, maintaining the epithelial state; in mesenchymal cells, ZEB-mediated repression blocks Sp1's ability to activate the miR-200 promoter despite maintained Sp1 expression. Knockdown of Sp1 induces EMT-associated marker changes.","method":"ChIP, reporter assay, Sp1 siRNA knockdown, EMSA, in vivo embryonic co-expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays, knockdown phenotype, in vivo corroboration, single lab","pmids":["24627491"],"is_preprint":false},{"year":2023,"finding":"HDAC2 regulates the M2-like TAM phenotype via acetylation of histone H3 and transcription factor SP1; pharmacologic or genetic HDAC2 inhibition reverses protumor macrophage polarization through the HDAC2-SP1 axis.","method":"HDAC2 genetic deletion (myeloid-specific KO), pharmacological HDAC inhibition, ChIP for SP1 acetylation, co-culture systems, four murine lung cancer models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing HDAC2-SP1 acetylation link, genetic and pharmacological evidence, multiple animal models, single lab","pmids":["37205635"],"is_preprint":false},{"year":2014,"finding":"Sp1 binds the GSDME promoter at the -36 to -28 site and promotes GSDME gene transcription; Sp1 knockdown or inhibition suppresses GSDME expression and reduces chemotherapy-induced pyroptosis. The regulation synergizes with STAT3 activity and antagonizes DNA methylation.","method":"ChIP, luciferase reporter assay, Sp1 siRNA knockdown, Sp1 inhibitor, STAT3 inhibitor, DNA methylation analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct promoter binding, functional knockdown phenotype, multiple inhibitor validations, single lab","pmids":["38238307"],"is_preprint":false},{"year":2008,"finding":"Sp1 is responsible for TRAIL induction by HDAC inhibitor MS275 alone or combined with Adriamycin in breast cancer cells; Sp1-knockout mouse embryonic stem cells and Sp1-knockdown cells are resistant to TRAIL induction and apoptosis by these combined treatments.","method":"Reporter constructs, ChIP, Sp1 siRNA knockdown, Sp1-knockout mouse embryonic stem cells, apoptosis assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, KO and KD models, functional apoptosis readout, single lab","pmids":["18701496"],"is_preprint":false},{"year":2014,"finding":"Pin1 interacts with the phospho-Thr739-Pro motif of Sp1 (confirmed by ITC and X-ray crystallography of Pin1 with the pThr739 peptide occupying Pin1 active site); this interaction promotes CDK1-mediated multisite phosphorylation of Sp1 (Ser720, Thr723, Thr737) during mitosis.","method":"X-ray crystallography, isothermal titration calorimetry, in vitro phosphorylation, co-IP","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional peptide, ITC binding quantification, mutagenesis validation","pmids":["25398907"],"is_preprint":false},{"year":2014,"finding":"PML induces SUMOylation of Sp1 in a RING-motif-dependent manner; SUMOylated Sp1 is recruited into PML nuclear bodies through interaction with PML's SUMO-binding motif, reducing Sp1 binding to target gene promoters and suppressing Sp1 transactivation.","method":"ChIP, immunofluorescence co-localization, nuclear matrix co-fractionation, SUMOylation assay, co-immunoprecipitation, PML RING and SBM mutants","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, co-localization, co-IP, domain mutagenesis, single lab","pmids":["24728382"],"is_preprint":false},{"year":2020,"finding":"SP1 governs primordial follicle formation in mice by controlling NOTCH2 expression: SP1 directly binds the Notch2 gene promoter in pregranulosa cells; knockdown of Sp1 in somatic cells suppresses nest breakdown, oocyte apoptosis, and primordial follicle formation.","method":"Conditional knockdown (Lgr5-KI reporter mouse, FOXL2+ cell-specific knockdown), ChIP for SP1 at Notch2 promoter, renal capsule transplantation","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct Notch2 promoter binding, cell-type-specific genetic knockdown with defined phenotype, single lab","pmids":["31282930"],"is_preprint":false},{"year":2019,"finding":"SP1 is required for stable hematopoietic differentiation trajectories; Sp1 DNA-binding domain mutation (Sp1ΔDBD/ΔDBD) distorts cell fate decision timing during hematopoiesis without dramatically altering distal accessible chromatin patterns, indicating Sp1 chromatin binding maintains robustness of differentiation rather than directing chromatin accessibility.","method":"Sp1ΔDBD/ΔDBD knock-in ES cells, hematopoietic differentiation assay, ATAC-seq, ChIP-seq, single-cell gene expression analysis","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knock-in, multi-omics, single-cell analysis, single lab","pmids":["31164147"],"is_preprint":false},{"year":2023,"finding":"SIRPA phosphorylates SP1 at Thr278 via ERK activation, protecting SP1 from proteasomal degradation; stabilized SP1 binds the SLC7A3 promoter to increase arginine uptake, which in turn further stabilizes SP1 in an ERK-independent manner, forming a 'SP1 stabilization circle' that promotes osteosarcoma metastasis.","method":"Co-immunoprecipitation, phosphorylation site mutagenesis (T278), proteasome inhibitor, ChIP for SP1 at SLC7A3 promoter, ERK inhibitor, xenograft model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-site mutagenesis, ChIP, pharmacological and genetic approaches, single lab","pmids":["37769797"],"is_preprint":false}],"current_model":"SP1 is a sequence-specific transcription factor whose three C-terminal Cys2-His2 zinc fingers bind GC-box DNA elements; it assembles into tetramers that mediate transcriptional synergy via DNA looping, and its activity is extensively regulated by post-translational modifications—including phosphorylation (by PKA, ERK2, cyclin A-CDK, CDK1, JNK1, ATM), sumoylation (at K16 and K683), O-GlcNAcylation, ubiquitination (via RNF4 as E3 ligase), deubiquitination (via USP39, ZRANB1), and caspase cleavage (at D183)—that control its DNA-binding activity, protein stability, subcellular localization, and interactions with co-regulators including Rb, STAT1, ERα/β, SIRT6, Hsp90, Pin1, PML, and TRRAP-HAT complexes, thereby integrating diverse signaling inputs to regulate transcription of hundreds of target genes in processes ranging from cell cycle progression and apoptosis to differentiation and the DNA damage response."},"narrative":{"mechanistic_narrative":"SP1 is a sequence-specific transcription factor that activates RNA polymerase II transcription through GC-box DNA elements bound by its C-terminal Zn(II) fingers, with separate domains controlling DNA-binding affinity and transactivation [PMID:3059495]. It assembles into stacked tetramers at DNA loop junctures, enabling long-range transcriptional synergism between distal and proximal GC boxes [PMID:2062845], and cooperates combinatorially with partner factors at adjacent sites — STAT1 for interferon-gamma-dependent ICAM-1 activation [PMID:8530443], Oct1 for U2 snRNA gene activation [PMID:19070619], and the retinoblastoma protein, which potentiates SP1 transactivation in part by liberating it from a negative regulator [PMID:1588949, PMID:8007947, PMID:9591776]. SP1 activity is countered at GC boxes by the competing repressor Sp3 [PMID:8070411] and by nuclear hormone receptors ERα/ERβ that bind its C-terminus to redirect transcription at GC-rich promoters [PMID:10681512]. SP1 function is heavily tuned by a layered post-translational code: phosphorylation by PKA, ERK2, cyclin A-CDK, CDK1, JNK1, and ATM modulates its DNA binding, stability, and chromatin residence [PMID:9261118, PMID:9918860, PMID:11598016, PMID:19245816, PMID:25398907, PMID:34550526]; O-GlcNAcylation blocks specific cofactor interactions [PMID:19070619]; and a SUMO/ubiquitin axis governs turnover, in which SUMO modification at Lys16 recruits the E3 ligase RNF4 for proteasomal degradation while phosphorylation events (e.g. JNK1/CDK1 at Thr739) or counteracting deubiquitinases (USP39, ZRANB1) protect the protein [PMID:21983342, PMID:24706897, PMID:34197957, PMID:34765294]. Through these inputs SP1 integrates cell-cycle, stress, and signaling cues: ATM-driven SUMO/RNF4 degradation enforces senescence [PMID:34550526], CDK1/Pin1-controlled phosphorylation displaces SP1 from chromosomes during mitosis to permit cell-cycle progression [PMID:25398907], and caspase cleavage at Asp183 yields a pro-apoptotic fragment [PMID:29236199]. SP1 also directs developmental and differentiation programs — maintaining the epithelial state via miR-200 [PMID:24627491], hematopoietic differentiation robustness [PMID:31164147], primordial follicle formation through Notch2 [PMID:31282930], and a TRRAP-dependent neuronal microtubule program [PMID:33594975] — and is recruited by chromatin regulators including SIRT6, which binds its zinc-finger domain to repress mTOR-pathway genes [PMID:31372634], and HDAC2 [PMID:37205635].","teleology":[{"year":1988,"claim":"Established the modular architecture of SP1, separating DNA recognition from transactivation and defining it as a bona fide Pol II activator.","evidence":"Deletion mutagenesis with E. coli-expressed fragments in an in vitro transcription assay","pmids":["3059495"],"confidence":"High","gaps":["Did not define the structural basis of GC-box recognition","Activation domain cofactor partners not identified"]},{"year":1991,"claim":"Answered how SP1 mediates synergy between distant promoter elements by showing it tetramerizes and loops DNA.","evidence":"Conventional and scanning transmission EM of SP1-DNA complexes","pmids":["2062845"],"confidence":"High","gaps":["Multimerization interface not mapped at residue level","In vivo relevance of looping geometry not tested"]},{"year":1994,"claim":"Defined how SP1 output is set at shared GC boxes by the competing repressor Sp3 and by Rb-mediated relief of an inhibitor.","evidence":"Competition/chimera reporter assays in SL2 cells; EMSA, recombinant Rb addition, and biochemical fractionation identifying Sp1-I","pmids":["8070411","8007947"],"confidence":"High","gaps":["Molecular identity of the ~20 kDa Sp1-I inhibitor not fully resolved","Direct vs. indirect Rb effect on SP1 DNA binding"]},{"year":1995,"claim":"Demonstrated combinatorial transcriptional synergy by showing SP1 physically partners with STAT1 at contiguous sites for interferon-gamma-dependent gene activation.","evidence":"Reciprocal co-IP from primary cells, EMSA, and reporter assays at the ICAM-1 promoter","pmids":["8530443"],"confidence":"High","gaps":["Interaction surface not mapped","Generality across other STAT-SP1 target genes not established"]},{"year":1997,"claim":"Showed phosphorylation can directly enhance SP1, linking PKA signaling to SP1 DNA-binding and transcriptional activity.","evidence":"In vitro kinase assay with recombinant SP1 plus PKA agonist/antagonist reporter pharmacology","pmids":["9261118"],"confidence":"Medium","gaps":["Phosphoacceptor residues not mapped","In vivo PKA target sites not confirmed"]},{"year":1999,"claim":"Placed SP1 downstream of the Ras-ERK cascade, with ERK2 phosphorylation stimulating SP1 DNA binding for growth-factor-inducible transcription.","evidence":"In vitro ERK2 phosphorylation, EMSA, dephosphorylation, and MEK-inhibitor epistasis at the gastrin promoter","pmids":["9918860"],"confidence":"Medium","gaps":["Specific ERK2 sites on SP1 not identified","Single-promoter context"]},{"year":2000,"claim":"Explained how estrogen signaling routes through SP1, with ERα/ERβ binding the SP1 C-terminus and using AF-1 to activate GC-rich promoters.","evidence":"Co-IP, pull-down, chimeric ER mapping, and AF-1 deletion reporter assays","pmids":["10681512"],"confidence":"High","gaps":["SP1 residues contacted by ER not mapped","Endogenous target gene repertoire not defined"]},{"year":2001,"claim":"Connected SP1 to cell-cycle control by showing cyclin A-CDK binds and phosphorylates SP1 at an N-terminal site to augment its DNA binding and activity.","evidence":"Co-IP, in vitro/in vivo phosphorylation, binding-site selection, and phospho-site mutagenesis reporter assays","pmids":["11598016"],"confidence":"High","gaps":["Exact target gene programs in S phase not delineated"]},{"year":2002,"claim":"Showed inflammatory signaling downregulates SP1, with LPS-driven Ser/Thr dephosphorylation and degradation reducing SP1-dependent gene expression.","evidence":"EMSA, IP-Western, in vitro dephosphorylation, and RT-PCR in a mouse lung model","pmids":["12089157"],"confidence":"Medium","gaps":["Phosphatase responsible not identified","Degradation pathway not defined"]},{"year":2008,"claim":"Integrated phosphorylation, sumoylation and ubiquitination into a coordinated processing/degradation program controlling SP1 turnover.","evidence":"In vitro SUMO/ubiquitination assays, site-directed mutagenesis, pulse-chase, and kinase inhibitor studies","pmids":["18239466"],"confidence":"Medium","gaps":["E3 ligase not identified at this stage","Protease for N-terminal cleavage unknown"]},{"year":2008,"claim":"Demonstrated SP1 is required for HDAC-inhibitor-induced TRAIL expression and apoptosis, linking SP1 to death-ligand transcription.","evidence":"Reporter constructs, ChIP, SP1 knockdown, and SP1-knockout mouse ES cells with apoptosis assays","pmids":["18701496"],"confidence":"Medium","gaps":["Direct SP1 binding element on TRAIL promoter not detailed","Mechanism of HDAC-inhibitor-driven SP1 activation unclear"]},{"year":2008,"claim":"Revealed O-GlcNAcylation as a switch that blocks specific SP1 cofactor interactions, suppressing SP1-Oct1 cooperative activation.","evidence":"Co-IP, O-GlcNAc site mapping, mutagenesis, and reporter assays at the U2 snRNA gene","pmids":["19070619"],"confidence":"Medium","gaps":["Whether O-GlcNAc affects other partners not tested","Dynamic regulation in vivo not addressed"]},{"year":2009,"claim":"Showed Hsp90 chaperones SP1 stability during mitosis via JNK1-mediated phosphorylation, preventing proteasomal degradation.","evidence":"Co-IP, geldanamycin treatment, shRNA knockdown, JNK1-site mutagenesis, and ubiquitination assay","pmids":["19245816"],"confidence":"Medium","gaps":["E3 ligase not yet identified","Direct vs. JNK1-dependent Hsp90 effect not separated"]},{"year":2011,"claim":"Identified RNF4 as the SUMO-targeted E3 ligase for SP1 and showed mitotic JNK1 phosphorylation at Thr739 protects SP1 from degradation.","evidence":"In vitro/in vivo ubiquitination, co-IP, and Lys16/Thr739 mutagenesis with proteasome inhibition","pmids":["21983342"],"confidence":"High","gaps":["Cell-cycle stoichiometry of SUMO-to-ubiquitin handoff not quantified"]},{"year":2014,"claim":"Resolved how mitotic SP1 is stabilized and removed from chromosomes by showing Pin1 binds phospho-Thr739 to drive CDK1 multisite phosphorylation.","evidence":"X-ray crystallography of Pin1-pThr739 peptide, ITC, in vitro phosphorylation, ChIP, and cell-cycle analysis","pmids":["25398907"],"confidence":"High","gaps":["Genes regulated by chromosome-displaced SP1 during mitosis not enumerated"]},{"year":2014,"claim":"Dissected opposing SUMO paralog effects, showing SUMO2 at Lys683/Lys16 attenuates DNA binding and increases turnover while SUMO1 is positive, controlling differentiation.","evidence":"In vivo/in vitro sumoylation, site mutagenesis, EMSA, ChIP, and a Lgr5-KI reporter mouse","pmids":["24706897"],"confidence":"High","gaps":["SUMO ligases directing paralog choice not fully defined"]},{"year":2014,"claim":"Established PML nuclear bodies as a sequestration mechanism that SUMOylates SP1 and removes it from target promoters.","evidence":"ChIP, IF co-localization, nuclear matrix co-fractionation, sumoylation assay, and PML RING/SBM mutants","pmids":["24728382"],"confidence":"Medium","gaps":["Reversibility/release from PML bodies not characterized","Target gene scope not defined"]},{"year":2014,"claim":"Defined an SP1-dependent epithelial maintenance program by showing SP1 activates the miR-200 family, antagonized by ZEB in mesenchymal states.","evidence":"ChIP, reporter assays, EMSA, SP1 knockdown, and in vivo embryonic co-expression analysis","pmids":["24627491"],"confidence":"Medium","gaps":["Mechanism of ZEB-mediated block on SP1 activity not resolved"]},{"year":2018,"claim":"Showed proteolytic conversion of SP1 to a pro-apoptotic effector via caspase cleavage at Asp183 generating the apoptosis-inducing Sp1-70C fragment.","evidence":"In vitro caspase cleavage, D183A mutagenesis, and gain/loss-of-function apoptosis assays","pmids":["29236199"],"confidence":"High","gaps":["Transcriptional targets of Sp1-70C not defined","Which caspase acts in vivo not pinned down"]},{"year":2019,"claim":"Identified SIRT6 as a deacetylase-independent repressor that binds the SP1 zinc-finger domain to restrain mTOR-pathway gene transcription.","evidence":"Domain-mapping co-IP, ChIP, reporter assays, mTOR-inhibitor rescue, and muscle-specific SIRT6 knockout mice","pmids":["31372634"],"confidence":"High","gaps":["How SIRT6 binding blocks SP1 without deacetylation not mechanistically resolved"]},{"year":2019,"claim":"Showed SP1 chromatin binding maintains robustness of cell-fate transitions rather than dictating chromatin accessibility during hematopoiesis.","evidence":"Sp1ΔDBD knock-in ES cells with hematopoietic differentiation, ATAC-seq, ChIP-seq, and single-cell expression","pmids":["31164147"],"confidence":"Medium","gaps":["Direct target genes governing fate timing not isolated"]},{"year":2020,"claim":"Connected SP1 to ovarian development by showing it directly drives Notch2 transcription required for primordial follicle formation.","evidence":"Cell-type-specific knockdown, ChIP at the Notch2 promoter, and renal capsule transplantation in mice","pmids":["31282930"],"confidence":"Medium","gaps":["Upstream control of SP1 in pregranulosa cells not defined"]},{"year":2021,"claim":"Showed DNA-damage signaling drives SP1 destruction via ATM-Ser101 phosphorylation triggering Lys16 SUMO and RNF4 degradation to enforce senescence.","evidence":"S101A/K16R mutagenesis, ATM and proteasome inhibitors, sumoylation assay, and senescence-marker analysis","pmids":["34550526"],"confidence":"High","gaps":["SP1 target genes whose loss drives senescence not enumerated"]},{"year":2021,"claim":"Identified deubiquitinases that oppose SP1 degradation, with USP39 and ZRANB1 directly binding and stabilizing SP1 to support proliferation and cancer phenotypes.","evidence":"Co-IP, ubiquitination assays, cycloheximide chase, knockdown/rescue, and xenografts","pmids":["34197957","34765294"],"confidence":"Medium","gaps":["DUB site specificity on SP1 ubiquitin chains not mapped","Single-lab reports for each DUB"]},{"year":2021,"claim":"Placed SP1 in a Keap1/cullin-RING ubiquitin network, acting as both a Keap1 ubiquitination substrate and a transcriptional regulator of CUL4A.","evidence":"Co-IP, ubiquitination assays, ChIP, siRNA knockdown, and reporter assays","pmids":["33895141"],"confidence":"Medium","gaps":["Direct vs. indirect Keap1-SP1 ubiquitination not fully separated"]},{"year":2021,"claim":"Demonstrated SP1 chromatin recruitment depends on TRRAP, defining a conserved SP1-driven microtubule-dynamics program in neurons.","evidence":"ChIP-seq in conditional Trrap knockout mice, multi-omics, and Stathmin3/4 rescue","pmids":["33594975"],"confidence":"High","gaps":["Whether TRRAP acts via SP1 acetylation or recruitment not resolved"]},{"year":2023,"claim":"Revealed SP1-stabilizing feedforward circuits in cancer, including SIRPA-ERK-Thr278 phosphorylation/SLC7A3 arginine uptake and HDAC2-mediated SP1 acetylation controlling macrophage polarization.","evidence":"Phospho-site mutagenesis, ChIP, ERK/proteasome inhibitors, and multiple murine tumor models","pmids":["37769797","37205635"],"confidence":"Medium","gaps":["Acetylation sites on SP1 modified by HDAC2 not mapped","Generality of the SP1 stabilization circuit beyond osteosarcoma untested"]},{"year":null,"claim":"How the dozens of competing post-translational inputs are quantitatively integrated to set context-specific SP1 target-gene selection remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking PTM combinations to specific gene programs","Structural basis of cofactor selection at GC boxes incomplete","Genome-wide SP1 target maps across signaling states not integrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3,5,23]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,10,32]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,4,19,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,16,30]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[16,23,31]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,5]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,14,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[18,27,28]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[20]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[25,31,32]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[15,17,21]}],"complexes":["PML nuclear bodies"],"partners":["RB1","STAT1","ESR1","RNF4","PIN1","SIRT6","PML","TRRAP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8N907","full_name":"DAN domain family member 5","aliases":["Cerberus-like protein 2","Cerl-2","Cysteine knot superfamily 1, BMP antagonist 3","Gremlin-3"],"length_aa":189,"mass_kda":20.2,"function":"Antagonist of the extracellular signaling protein NODAL, which is required for correct left-right patterning during embryonic development (By similarity). Antagonist of BMP and TGF-beta signaling (PubMed:33587337). Independently of its role in left-right axis establishment, plays a role during heart development, possibly through the regulation of TGF-beta/Nodal signaling pathway (By similarity). Displays anti-angiogenic activity by inhibiting endothelial sprouting, migration, and proliferation. Once internalized by endothelial cells, may alter their redox and glycolytic balance (PubMed:33587337)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q8N907/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SP1","classification":"Not Classified","n_dependent_lines":191,"n_total_lines":1208,"dependency_fraction":0.15811258278145696},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SP1","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"620990","title":"ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 3; AIMAH3","url":"https://www.omim.org/entry/620990"},{"mim_id":"620079","title":"LONG INTERGENIC NONCODING RNA 467; LINC00467","url":"https://www.omim.org/entry/620079"},{"mim_id":"619066","title":"ZINC FINGER PROTEIN 532; ZNF532","url":"https://www.omim.org/entry/619066"},{"mim_id":"618742","title":"ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8A; ZBTB8A","url":"https://www.omim.org/entry/618742"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SP1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q8N907","domains":[{"cath_id":"2.10.90.10","chopping":"89-188","consensus_level":"medium","plddt":89.6669,"start":89,"end":188}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N907","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N907-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N907-F1-predicted_aligned_error_v6.png","plddt_mean":69.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SP1","jax_strain_url":"https://www.jax.org/strain/search?query=SP1"},"sequence":{"accession":"Q8N907","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N907.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N907/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N907"}},"corpus_meta":[{"pmid":"12620113","id":"PMC_12620113","title":"Sp1- and Krüppel-like transcription factors.","date":"2003","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/12620113","citation_count":833,"is_preprint":false},{"pmid":"8070411","id":"PMC_8070411","title":"Sp1-mediated transcriptional activation is repressed by Sp3.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8070411","citation_count":676,"is_preprint":false},{"pmid":"2005904","id":"PMC_2005904","title":"Developmental expression of Sp1 in the mouse.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2005904","citation_count":528,"is_preprint":false},{"pmid":"25393971","id":"PMC_25393971","title":"Sp1 and the 'hallmarks of cancer'.","date":"2015","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25393971","citation_count":448,"is_preprint":false},{"pmid":"15284899","id":"PMC_15284899","title":"Gene regulation by Sp1 and Sp3.","date":"2004","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/15284899","citation_count":354,"is_preprint":false},{"pmid":"25960131","id":"PMC_25960131","title":"Sp1 transcription factor: A long-standing target in cancer chemotherapy.","date":"2015","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25960131","citation_count":346,"is_preprint":false},{"pmid":"3059495","id":"PMC_3059495","title":"Distinct regions of Sp1 modulate DNA binding and transcriptional activation.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3059495","citation_count":336,"is_preprint":false},{"pmid":"10681512","id":"PMC_10681512","title":"Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10681512","citation_count":331,"is_preprint":false},{"pmid":"20810260","id":"PMC_20810260","title":"The role of Sp1 and Sp3 in normal and cancer cell biology.","date":"2010","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/20810260","citation_count":284,"is_preprint":false},{"pmid":"1588949","id":"PMC_1588949","title":"The retinoblastoma gene product regulates Sp1-mediated transcription.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1588949","citation_count":260,"is_preprint":false},{"pmid":"8530443","id":"PMC_8530443","title":"Stat1 depends on transcriptional synergy with Sp1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8530443","citation_count":238,"is_preprint":false},{"pmid":"2062845","id":"PMC_2062845","title":"DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2062845","citation_count":238,"is_preprint":false},{"pmid":"9261118","id":"PMC_9261118","title":"Modulation of transcription factor Sp1 by cAMP-dependent protein kinase.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9261118","citation_count":196,"is_preprint":false},{"pmid":"8007947","id":"PMC_8007947","title":"The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8007947","citation_count":189,"is_preprint":false},{"pmid":"9918860","id":"PMC_9918860","title":"Sp1 phosphorylation by Erk 2 stimulates DNA binding.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9918860","citation_count":181,"is_preprint":false},{"pmid":"16266294","id":"PMC_16266294","title":"The family feud: turning off Sp1 by Sp1-like KLF proteins.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16266294","citation_count":168,"is_preprint":false},{"pmid":"22158040","id":"PMC_22158040","title":"Sp1 expression regulates lung tumor progression.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22158040","citation_count":119,"is_preprint":false},{"pmid":"35821227","id":"PMC_35821227","title":"TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35821227","citation_count":110,"is_preprint":false},{"pmid":"22022994","id":"PMC_22022994","title":"Targeting Sp1 transcription factors in prostate cancer therapy.","date":"2011","source":"Medicinal chemistry (Shariqah (United Arab Emirates))","url":"https://pubmed.ncbi.nlm.nih.gov/22022994","citation_count":104,"is_preprint":false},{"pmid":"11598016","id":"PMC_11598016","title":"Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11598016","citation_count":103,"is_preprint":false},{"pmid":"11579201","id":"PMC_11579201","title":"Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif.","date":"2001","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11579201","citation_count":93,"is_preprint":false},{"pmid":"16715126","id":"PMC_16715126","title":"Overexpression of Sp1 transcription factor induces apoptosis.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16715126","citation_count":91,"is_preprint":false},{"pmid":"34322883","id":"PMC_34322883","title":"LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34322883","citation_count":87,"is_preprint":false},{"pmid":"17350596","id":"PMC_17350596","title":"Sp1 and Sp3 regulate basal transcription of the survivin gene.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17350596","citation_count":79,"is_preprint":false},{"pmid":"18579560","id":"PMC_18579560","title":"Sp1 and p73 activate PUMA following serum starvation.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18579560","citation_count":73,"is_preprint":false},{"pmid":"24519909","id":"PMC_24519909","title":"Sp1-mediated microRNA-182 expression regulates lung cancer progression.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24519909","citation_count":72,"is_preprint":false},{"pmid":"24706897","id":"PMC_24706897","title":"Sumoylation differentially regulates Sp1 to control cell differentiation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24706897","citation_count":70,"is_preprint":false},{"pmid":"18769160","id":"PMC_18769160","title":"Regulation of Sp1 by cell cycle related proteins.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18769160","citation_count":69,"is_preprint":false},{"pmid":"22342309","id":"PMC_22342309","title":"Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.","date":"2012","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22342309","citation_count":65,"is_preprint":false},{"pmid":"21983342","id":"PMC_21983342","title":"Interplay of posttranslational modifications in Sp1 mediates Sp1 stability during cell cycle progression.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21983342","citation_count":63,"is_preprint":false},{"pmid":"17161377","id":"PMC_17161377","title":"Downregulation of transcription factor, Sp1, during cellular senescence.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17161377","citation_count":63,"is_preprint":false},{"pmid":"31400609","id":"PMC_31400609","title":"Circular RNA circSCAF11 Accelerates the Glioma Tumorigenesis through the miR-421/SP1/VEGFA Axis.","date":"2019","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/31400609","citation_count":62,"is_preprint":false},{"pmid":"24627491","id":"PMC_24627491","title":"Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24627491","citation_count":59,"is_preprint":false},{"pmid":"26352013","id":"PMC_26352013","title":"Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26352013","citation_count":54,"is_preprint":false},{"pmid":"10987820","id":"PMC_10987820","title":"Tau promoter confers neuronal specificity and binds Sp1 and AP-2.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10987820","citation_count":54,"is_preprint":false},{"pmid":"18193911","id":"PMC_18193911","title":"SP1 protein-based nanostructures and arrays.","date":"2008","source":"Nano letters","url":"https://pubmed.ncbi.nlm.nih.gov/18193911","citation_count":53,"is_preprint":false},{"pmid":"12089157","id":"PMC_12089157","title":"Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12089157","citation_count":52,"is_preprint":false},{"pmid":"15816870","id":"PMC_15816870","title":"Sp1 and Sp3 activate transcription of the human dopamine transporter gene.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15816870","citation_count":52,"is_preprint":false},{"pmid":"8276776","id":"PMC_8276776","title":"Comparison of DNA-binding properties between BTEB and Sp1.","date":"1993","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8276776","citation_count":51,"is_preprint":false},{"pmid":"37205635","id":"PMC_37205635","title":"The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.","date":"2023","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37205635","citation_count":50,"is_preprint":false},{"pmid":"29749377","id":"PMC_29749377","title":"P2RX7-MAPK1/2-SP1 axis inhibits MTOR independent HSPB1-mediated astroglial autophagy.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29749377","citation_count":47,"is_preprint":false},{"pmid":"12429135","id":"PMC_12429135","title":"Sp1 is essential for estrogen receptor alpha gene transcription.","date":"2002","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12429135","citation_count":46,"is_preprint":false},{"pmid":"9591776","id":"PMC_9591776","title":"Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9591776","citation_count":44,"is_preprint":false},{"pmid":"14645238","id":"PMC_14645238","title":"E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14645238","citation_count":44,"is_preprint":false},{"pmid":"11870074","id":"PMC_11870074","title":"Sp1 and Egr1 regulate transcription of the Dmrt1 gene in Sertoli cells.","date":"2002","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11870074","citation_count":44,"is_preprint":false},{"pmid":"34197957","id":"PMC_34197957","title":"USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma.","date":"2021","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/34197957","citation_count":43,"is_preprint":false},{"pmid":"1688466","id":"PMC_1688466","title":"A naturally occurring gamma globin gene mutation enhances SP1 binding activity.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1688466","citation_count":43,"is_preprint":false},{"pmid":"31372634","id":"PMC_31372634","title":"SIRT6 transcriptionally regulates global protein synthesis through transcription factor Sp1 independent of its deacetylase activity.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31372634","citation_count":43,"is_preprint":false},{"pmid":"8892232","id":"PMC_8892232","title":"buttonhead and D-Sp1: a novel Drosophila gene pair.","date":"1996","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8892232","citation_count":42,"is_preprint":false},{"pmid":"23601184","id":"PMC_23601184","title":"Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.","date":"2013","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/23601184","citation_count":42,"is_preprint":false},{"pmid":"18701496","id":"PMC_18701496","title":"Sp1-mediated TRAIL induction in chemosensitization.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18701496","citation_count":38,"is_preprint":false},{"pmid":"39630109","id":"PMC_39630109","title":"Chronic Stress-Induced and Tumor Derived SP1+ Exosomes Polarizing IL-1β+ Neutrophils to Increase Lung Metastasis of Breast Cancer.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39630109","citation_count":37,"is_preprint":false},{"pmid":"18226599","id":"PMC_18226599","title":"Sp1 transcription factor as a target for anthracyclines: effects on gene transcription.","date":"2008","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/18226599","citation_count":37,"is_preprint":false},{"pmid":"38238307","id":"PMC_38238307","title":"Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38238307","citation_count":36,"is_preprint":false},{"pmid":"17981566","id":"PMC_17981566","title":"MT-SP1 proteolysis and regulation of cell-microenvironment interactions.","date":"2008","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/17981566","citation_count":36,"is_preprint":false},{"pmid":"31282930","id":"PMC_31282930","title":"SP1 governs primordial folliculogenesis by regulating pregranulosa cell development in mice.","date":"2020","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31282930","citation_count":36,"is_preprint":false},{"pmid":"18239466","id":"PMC_18239466","title":"Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18239466","citation_count":36,"is_preprint":false},{"pmid":"32375633","id":"PMC_32375633","title":"The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer.","date":"2020","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/32375633","citation_count":34,"is_preprint":false},{"pmid":"19111069","id":"PMC_19111069","title":"Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.","date":"2008","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19111069","citation_count":33,"is_preprint":false},{"pmid":"10497252","id":"PMC_10497252","title":"Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10497252","citation_count":33,"is_preprint":false},{"pmid":"35715606","id":"PMC_35715606","title":"Role of Sp1 in atherosclerosis.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35715606","citation_count":32,"is_preprint":false},{"pmid":"37769797","id":"PMC_37769797","title":"SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37769797","citation_count":32,"is_preprint":false},{"pmid":"31009133","id":"PMC_31009133","title":"SP1 regulates KLF4 via SP1 binding motif governed by DNA methylation during odontoblastic differentiation of human dental pulp cells.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31009133","citation_count":31,"is_preprint":false},{"pmid":"19245816","id":"PMC_19245816","title":"Heat shock protein 90 is important for Sp1 stability during mitosis.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19245816","citation_count":31,"is_preprint":false},{"pmid":"29236199","id":"PMC_29236199","title":"Caspase cleavage of transcription factor Sp1 enhances apoptosis.","date":"2018","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/29236199","citation_count":28,"is_preprint":false},{"pmid":"29273682","id":"PMC_29273682","title":"Downregulation of decidual SP1 and P300 is associated with severe preeclampsia.","date":"2017","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29273682","citation_count":28,"is_preprint":false},{"pmid":"29655291","id":"PMC_29655291","title":"Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/29655291","citation_count":28,"is_preprint":false},{"pmid":"19070619","id":"PMC_19070619","title":"O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19070619","citation_count":28,"is_preprint":false},{"pmid":"32016481","id":"PMC_32016481","title":"SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32016481","citation_count":26,"is_preprint":false},{"pmid":"34066653","id":"PMC_34066653","title":"Sp1-Mediated circRNA circHipk2 Regulates Myogenesis by Targeting Ribosomal Protein Rpl7.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34066653","citation_count":26,"is_preprint":false},{"pmid":"31164147","id":"PMC_31164147","title":"Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.","date":"2019","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/31164147","citation_count":26,"is_preprint":false},{"pmid":"25398907","id":"PMC_25398907","title":"Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25398907","citation_count":26,"is_preprint":false},{"pmid":"32721022","id":"PMC_32721022","title":"ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32721022","citation_count":25,"is_preprint":false},{"pmid":"37147632","id":"PMC_37147632","title":"Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37147632","citation_count":24,"is_preprint":false},{"pmid":"31317491","id":"PMC_31317491","title":"Sp1 in Astrocyte Is Important for Neurite Outgrowth and Synaptogenesis.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31317491","citation_count":23,"is_preprint":false},{"pmid":"29654167","id":"PMC_29654167","title":"MiR-150-3p targets SP1 and suppresses the growth of glioma cells.","date":"2018","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/29654167","citation_count":23,"is_preprint":false},{"pmid":"29328444","id":"PMC_29328444","title":"SP1 reduces autophagic flux through activating p62 in gastric cancer cells.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29328444","citation_count":23,"is_preprint":false},{"pmid":"12421830","id":"PMC_12421830","title":"Sp1 transactivation of the TCL1 oncogene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12421830","citation_count":23,"is_preprint":false},{"pmid":"27182621","id":"PMC_27182621","title":"The Genomic Context and Corecruitment of SP1 Affect ERRα Coactivation by PGC-1α in Muscle Cells.","date":"2016","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/27182621","citation_count":23,"is_preprint":false},{"pmid":"11890673","id":"PMC_11890673","title":"Sp1 and Sp3 activate the rat connexin40 proximal promoter.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11890673","citation_count":22,"is_preprint":false},{"pmid":"22984509","id":"PMC_22984509","title":"Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22984509","citation_count":22,"is_preprint":false},{"pmid":"33069434","id":"PMC_33069434","title":"SP1-independent inhibition of FOXM1 by modified thiazolidinediones.","date":"2020","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33069434","citation_count":21,"is_preprint":false},{"pmid":"33239622","id":"PMC_33239622","title":"Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33239622","citation_count":21,"is_preprint":false},{"pmid":"34830324","id":"PMC_34830324","title":"Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34830324","citation_count":20,"is_preprint":false},{"pmid":"34550526","id":"PMC_34550526","title":"DNA damage-induced degradation of Sp1 promotes cellular senescence.","date":"2021","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/34550526","citation_count":19,"is_preprint":false},{"pmid":"34765294","id":"PMC_34765294","title":"Deubiquitinase ZRANB1 drives hepatocellular carcinoma progression through SP1-LOXL2 axis.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34765294","citation_count":19,"is_preprint":false},{"pmid":"21029371","id":"PMC_21029371","title":"Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21029371","citation_count":18,"is_preprint":false},{"pmid":"20882567","id":"PMC_20882567","title":"Sp1 phosphorylation is involved in myelin basic protein gene transcription.","date":"2010","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/20882567","citation_count":18,"is_preprint":false},{"pmid":"12445596","id":"PMC_12445596","title":"Steroid hormones, endometrial gene regulation and the Sp1 family of proteins.","date":"2002","source":"Journal of the Society for Gynecologic Investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12445596","citation_count":18,"is_preprint":false},{"pmid":"33594975","id":"PMC_33594975","title":"HAT cofactor TRRAP modulates microtubule dynamics via SP1 signaling to prevent neurodegeneration.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33594975","citation_count":18,"is_preprint":false},{"pmid":"39062521","id":"PMC_39062521","title":"Role of Specificity Protein 1 (SP1) in Cardiovascular Diseases: Pathological Mechanisms and Therapeutic Potentials.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39062521","citation_count":17,"is_preprint":false},{"pmid":"18655767","id":"PMC_18655767","title":"Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1.","date":"2008","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/18655767","citation_count":17,"is_preprint":false},{"pmid":"30674964","id":"PMC_30674964","title":"SP1 and RARα regulate AGAP2 expression in cancer.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30674964","citation_count":16,"is_preprint":false},{"pmid":"15860659","id":"PMC_15860659","title":"Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene.","date":"2005","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/15860659","citation_count":16,"is_preprint":false},{"pmid":"29565456","id":"PMC_29565456","title":"SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29565456","citation_count":15,"is_preprint":false},{"pmid":"26341485","id":"PMC_26341485","title":"Down-regulation of EPHX2 gene transcription by Sp1 under high-glucose conditions.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26341485","citation_count":15,"is_preprint":false},{"pmid":"24728382","id":"PMC_24728382","title":"Inhibition of Sp1 functions by its sequestration into PML nuclear bodies.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24728382","citation_count":15,"is_preprint":false},{"pmid":"20141633","id":"PMC_20141633","title":"Sp1 and KLF15 regulate basal transcription of the human LRP5 gene.","date":"2010","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20141633","citation_count":15,"is_preprint":false},{"pmid":"33895141","id":"PMC_33895141","title":"Sp1 is a substrate of Keap1 and regulates the activity of CRL4AWDR23 ubiquitin ligase toward Nrf2.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33895141","citation_count":15,"is_preprint":false},{"pmid":"12801994","id":"PMC_12801994","title":"Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12801994","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46043,"output_tokens":8121,"usd":0.129972,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17716,"output_tokens":7136,"usd":0.13349,"stage2_stop_reason":"end_turn"},"total_usd":0.263462,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"Sp1 contains distinct regions for DNA binding and transcriptional activation: Zn(II) fingers confer sequence-specific DNA binding, a separate region regulates DNA-binding affinity, and at least two distinct segments contribute to transcriptional activation of RNA polymerase II in vitro.\",\n      \"method\": \"Deletion mutagenesis, E. coli expression of Sp1 fragments, in vitro transcription assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, foundational study replicated across subsequent work\",\n      \"pmids\": [\"3059495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Sp1 forms tetramers and assembles multiple stacked tetramers at DNA loop junctures, mediating long-range transcriptional synergism between distal and proximal GC box elements via DNA looping.\",\n      \"method\": \"Conventional and scanning transmission electron microscopy of Sp1-DNA complexes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct structural visualization by two EM modalities with functional context\",\n      \"pmids\": [\"2062845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Retinoblastoma protein (Rb) positively regulates Sp1 transcriptional activity; using a GAL4-Sp1 fusion protein, Rb was shown to directly stimulate Sp1-mediated transactivation in vivo.\",\n      \"method\": \"GAL4-Sp1 fusion co-transfection, reporter gene assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay with fusion protein, single lab, corroborated by PMID:8007947\",\n      \"pmids\": [\"1588949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for common GC-box DNA binding sites; chimeric protein analysis showed that neither the glutamine-rich A/B domains nor the D domain of Sp1 can be functionally replaced by the homologous Sp3 regions.\",\n      \"method\": \"Co-transfection reporter assays in mammalian cells and Sp-factor-deficient Drosophila SL2 cells, antibody generation, chimeric protein expression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (competition assay, chimeric proteins, SL2 cell reconstitution), replicated across cell lines\",\n      \"pmids\": [\"8070411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Rb stimulates Sp1-mediated transactivation by liberating Sp1 from a ~20 kDa negative regulator protein (Sp1-I); recombinant Rb reversed Sp1-I-mediated inhibition of Sp1 DNA binding, and Sp1-I was identified as an RB-associated protein.\",\n      \"method\": \"Mobility shift assay, antibody supershift, recombinant protein addition, co-transfection with GAL4-Sp1, identification of Sp1-I by biochemical fractionation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (EMSA, co-transfection, biochemical fractionation), single lab\",\n      \"pmids\": [\"8007947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Stat1 and Sp1 physically interact (co-immunoprecipitation from primary cells without overexpression) and both must occupy contiguous DNA binding sites for full interferon-gamma-dependent activation of the ICAM-1 gene, demonstrating transcriptional synergy.\",\n      \"method\": \"Co-immunoprecipitation, DNA/protein binding assay (EMSA), transfected reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP from primary cells, multiple orthogonal methods, functional epistasis confirmed\",\n      \"pmids\": [\"8530443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"cAMP-dependent protein kinase (PKA) activates Sp1 transcriptional and DNA-binding activity; recombinant Sp1 DNA-binding activity is stimulated by exogenous PKA in vitro, and PKA antagonists inhibit Sp1-dependent reporter activity.\",\n      \"method\": \"In vitro kinase assay with recombinant Sp1, insect-cell co-transfection reporter assay, PKA agonist/antagonist pharmacology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution with recombinant proteins plus cell-based validation, single lab\",\n      \"pmids\": [\"9261118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rb physically associates with Sp1 in nuclear complexes across all cell cycle phases (reciprocal co-immunoprecipitation and supershift), and this association potentiates Sp1-mediated transcription of the DHFR promoter through its GC box.\",\n      \"method\": \"Co-immunoprecipitation, EMSA supershift, immunodepletion, co-transfection reporter assay with GC-box point mutant\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, EMSA supershift, functional mutagenesis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"9591776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ERK2 phosphorylates Sp1 and stimulates its DNA-binding activity; pretreatment of cell extracts with recombinant ERK2 increased Sp1 binding, while dephosphorylation reduced it. The Ras-ERK cascade mediates EGF-inducible gastrin promoter activation through Sp1.\",\n      \"method\": \"In vitro phosphorylation with recombinant ERK2, EMSA, dephosphorylation assay, co-transfection with dominant-negative/active constructs, MEK inhibitor (PD98059)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus cell-based epistasis, single lab\",\n      \"pmids\": [\"9918860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ERα and ERβ physically interact with Sp1 (co-immunoprecipitation) and preferentially bind the C-terminal region of Sp1 (pull-down assay); the AF-1 domain (amino acids 79–117) of ERα is required for transcriptional activation at GC-rich Sp1 promoter elements.\",\n      \"method\": \"Co-immunoprecipitation, pull-down assay, chimeric ER expression, transactivation reporter assay, AF-1 deletion analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, pull-down, chimeric protein mapping, multiple cell lines\",\n      \"pmids\": [\"10681512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cyclin A-CDK complexes physically interact with Sp1 (co-immunoprecipitation) and phosphorylate it in vitro and in vivo at an N-terminal site; this phosphorylation augments Sp1 DNA-binding activity and transcriptional activation. Mutation of the phosphorylation site abolished cyclin A-CDK-dependent effects.\",\n      \"method\": \"Co-immunoprecipitation, in vitro and in vivo phosphorylation assay, DNA binding site selection/PCR, co-transfection reporter assay, phosphorylation-site mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay, mutagenesis, co-IP, functional reporter assay, multiple orthogonal methods\",\n      \"pmids\": [\"11598016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LPS dephosphorylates Sp1 at serine and threonine residues (but not tyrosine) in vivo and promotes Sp1 protein degradation, both of which reduce Sp1 DNA-binding activity and decrease expression of Sp1-dependent target genes (eNOS, COX-1).\",\n      \"method\": \"EMSA, immunoprecipitation-Western blot, in vitro dephosphorylation, nuclear fractionation, RT-PCR, in vivo mouse lung model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in vivo and in vitro, single lab\",\n      \"pmids\": [\"12089157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sp1 undergoes phosphorylation-driven proteolytic processing, desumoylation, and degradation: Ser59 regulates N-terminal cleavage; Lys16 is the SUMO-1/ubiquitin target; Ser7 enhances ubiquitination; PKCα and the PKC-ERK-ERBB2 axis drive Sp1 processing. CyclinA/CDK2 phosphorylation of Ser59 relieves SUMO-mediated repression.\",\n      \"method\": \"In vitro sumoylation/ubiquitination assays, site-directed mutagenesis, kinase inhibitor studies, pulse-chase, co-transfection\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays and mutagenesis, single lab\",\n      \"pmids\": [\"18239466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"O-GlcNAc modification within the second serine/threonine-rich region of Sp1 inhibits the physical interaction between Sp1 and Oct1, thereby suppressing cooperative activation of the U2 snRNA gene.\",\n      \"method\": \"Co-immunoprecipitation, O-GlcNAc site mapping, transcriptional reporter assay, site-directed mutagenesis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical interaction and functional reporter with mutagenesis, single lab\",\n      \"pmids\": [\"19070619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hsp90 interacts with Sp1 during mitosis and maintains Sp1 stability via JNK1-mediated phosphorylation at Thr278 and Thr739; inhibition or knockdown of Hsp90 decreases JNK1 activity and leads to ubiquitin-dependent proteasomal degradation of Sp1 during mitosis.\",\n      \"method\": \"Co-immunoprecipitation, geldanamycin treatment, shRNA knockdown, site-directed mutagenesis of JNK1 phosphorylation sites, ubiquitination assay\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, mutagenesis, and knockdown with functional readout, single lab\",\n      \"pmids\": [\"19245816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RNF4 is the ubiquitin E3 ligase for Sp1: sumoylated Sp1 (at Lys16) recruits RNF4, leading to proteasomal degradation. JNK1-mediated phosphorylation of Sp1 at Thr739 during mitosis abolishes the Sp1-RNF4 interaction, protecting Sp1 from degradation and maintaining its levels for cell division.\",\n      \"method\": \"In vitro and in vivo ubiquitination assays, co-immunoprecipitation, site-directed mutagenesis (Lys16, Thr739), domain mapping, proteasome inhibitor\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution, mutagenesis of key sites, co-IP, multiple orthogonal methods in single study\",\n      \"pmids\": [\"21983342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pin1 is recruited to the phospho-Thr739-Pro motif of Sp1 and facilitates CDK1-mediated phosphorylation at Ser720, Thr723, and Thr737 during mitosis; X-ray crystallography confirmed Pin1 binding to the pThr739 peptide. Increased CDK1 phosphorylation stabilizes Sp1 (via reduced RNF4 interaction) and displaces it from chromosomes, facilitating cell cycle progression.\",\n      \"method\": \"Isothermal titration calorimetry, X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation, in vitro phosphorylation, ChIP, cell cycle analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of Pin1-pSp1 peptide complex, ITC binding quantification, mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"25398907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SUMO2 negatively regulates Sp1 by: (1) sumoylating Sp1 at Lys683 to attenuate DNA binding; (2) sumoylating Sp1 at Lys16 to increase its turnover; and (3) interfering with the Sp1-p300 coactivator interaction and recruiting Sp3 repressor. SUMO1 positively regulates Sp1 and forms complexes with it; these differential SUMO modifications control lens cell differentiation.\",\n      \"method\": \"Co-immunoprecipitation, in vivo and in vitro sumoylation assays, site-directed mutagenesis (K683, K16), EMSA, ChIP, reporter assays, SUMO1/2/3 knockdown/overexpression, Lgr5-KI reporter mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple sumoylation site mutants, in vitro and in vivo assays, animal model, multiple orthogonal methods\",\n      \"pmids\": [\"24706897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Caspase cleavage of Sp1 at Asp183 (identified in vitro) produces a 70 kDa C-terminal fragment (Sp1-70C, aa 184–785); the Sp1-D183A mutant is resistant to cleavage and renders cells resistant to apoptotic stimuli, whereas Sp1-70C overexpression induces apoptosis, demonstrating that caspase cleavage of Sp1 promotes apoptosis.\",\n      \"method\": \"In vitro caspase cleavage assay, site-directed mutagenesis (D183A), ectopic expression of cleavage-resistant and truncated Sp1 forms, apoptosis assays (DNA damage, TRAIL)\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro cleavage with mutagenesis, functional gain/loss-of-function with defined phenotypic readout, multiple stimuli\",\n      \"pmids\": [\"29236199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT6 binds directly to the zinc finger DNA-binding domain of Sp1 and represses its transcriptional activity, independent of SIRT6 deacetylase activity; SIRT6 deficiency increases Sp1 occupancy at mTOR signaling gene promoters, activating mTOR and increasing global protein synthesis.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping pull-down, ChIP, reporter assays, mTOR inhibitor rescue, muscle-specific SIRT6 knockout mice, pharmacological inhibition\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-mapping co-IP, ChIP, genetic KO model, pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"31372634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ATM phosphorylation of Sp1 (at Ser101) in response to DNA damage triggers its sumoylation at Lys16 and subsequent RNF4-mediated proteasomal degradation, driving cellular senescence; Sp1 phospho-null (S101A) or sumo-null (K16R) mutants resist degradation and reduce senescence markers.\",\n      \"method\": \"Site-directed mutagenesis (S101A, K16R), ATM inhibitor, proteasome inhibitor, sumoylation assay, senescence marker analysis (SA-β-gal, p21, p16)\",\n      \"journal\": \"GeroScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phospho-null and sumo-null mutagenesis with defined phenotypic readout, genetic and pharmacological epistasis, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"34550526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP39 deubiquitinates and stabilizes SP1 protein, prolonging its half-life; SP1 is identified as a substrate of USP39, and knockdown of USP39 promotes SP1 degradation, with SP1 overexpression reversing USP39-knockdown-induced apoptosis and cell cycle arrest.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, cycloheximide chase (half-life measurement), siRNA knockdown/rescue, in vivo xenograft\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, biochemical deubiquitination evidence, functional rescue, single lab\",\n      \"pmids\": [\"34197957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZRANB1 directly binds SP1 and stabilizes it through deubiquitination; ZRANB1-SP1 axis regulates LOXL2 transcription to promote HCC growth and metastasis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function studies, RNA-seq, xenograft\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding shown by co-IP, biochemical deubiquitination, functional rescue, single lab\",\n      \"pmids\": [\"34765294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TRRAP is required for SP1 binding at promoters of microtubule dynamics genes in Purkinje neurons; TRRAP loss reduces SP1 chromatin occupancy and disrupts a conserved SP1-dependent transcriptional program, with ectopic expression of Stathmin3/4 rescuing TRRAP-deficient neuronal defects.\",\n      \"method\": \"Integrated transcriptomics, epigenomics (ChIP-seq), proteomics, conditional Trrap knockout mice, ectopic gene expression rescue\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq in KO model, multi-omics, genetic rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"33594975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Sp1 is a substrate of Keap1: Sp1 physically interacts with Keap1, which promotes Sp1 ubiquitination. Sp1 in turn regulates CUL4A expression by binding its promoter, and SP1 regulates Nrf2 protein levels via the CRL4AWDR23 ubiquitin ligase complex.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, ChIP, siRNA knockdown, reporter assays, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, biochemical ubiquitination, ChIP, multiple knockdown experiments, single lab\",\n      \"pmids\": [\"33895141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sp1 binds to the miR-200b~200a~429 proximal promoter and activates miR-200 family expression in epithelial cells, maintaining the epithelial state; in mesenchymal cells, ZEB-mediated repression blocks Sp1's ability to activate the miR-200 promoter despite maintained Sp1 expression. Knockdown of Sp1 induces EMT-associated marker changes.\",\n      \"method\": \"ChIP, reporter assay, Sp1 siRNA knockdown, EMSA, in vivo embryonic co-expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays, knockdown phenotype, in vivo corroboration, single lab\",\n      \"pmids\": [\"24627491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HDAC2 regulates the M2-like TAM phenotype via acetylation of histone H3 and transcription factor SP1; pharmacologic or genetic HDAC2 inhibition reverses protumor macrophage polarization through the HDAC2-SP1 axis.\",\n      \"method\": \"HDAC2 genetic deletion (myeloid-specific KO), pharmacological HDAC inhibition, ChIP for SP1 acetylation, co-culture systems, four murine lung cancer models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing HDAC2-SP1 acetylation link, genetic and pharmacological evidence, multiple animal models, single lab\",\n      \"pmids\": [\"37205635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sp1 binds the GSDME promoter at the -36 to -28 site and promotes GSDME gene transcription; Sp1 knockdown or inhibition suppresses GSDME expression and reduces chemotherapy-induced pyroptosis. The regulation synergizes with STAT3 activity and antagonizes DNA methylation.\",\n      \"method\": \"ChIP, luciferase reporter assay, Sp1 siRNA knockdown, Sp1 inhibitor, STAT3 inhibitor, DNA methylation analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct promoter binding, functional knockdown phenotype, multiple inhibitor validations, single lab\",\n      \"pmids\": [\"38238307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sp1 is responsible for TRAIL induction by HDAC inhibitor MS275 alone or combined with Adriamycin in breast cancer cells; Sp1-knockout mouse embryonic stem cells and Sp1-knockdown cells are resistant to TRAIL induction and apoptosis by these combined treatments.\",\n      \"method\": \"Reporter constructs, ChIP, Sp1 siRNA knockdown, Sp1-knockout mouse embryonic stem cells, apoptosis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, KO and KD models, functional apoptosis readout, single lab\",\n      \"pmids\": [\"18701496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pin1 interacts with the phospho-Thr739-Pro motif of Sp1 (confirmed by ITC and X-ray crystallography of Pin1 with the pThr739 peptide occupying Pin1 active site); this interaction promotes CDK1-mediated multisite phosphorylation of Sp1 (Ser720, Thr723, Thr737) during mitosis.\",\n      \"method\": \"X-ray crystallography, isothermal titration calorimetry, in vitro phosphorylation, co-IP\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional peptide, ITC binding quantification, mutagenesis validation\",\n      \"pmids\": [\"25398907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PML induces SUMOylation of Sp1 in a RING-motif-dependent manner; SUMOylated Sp1 is recruited into PML nuclear bodies through interaction with PML's SUMO-binding motif, reducing Sp1 binding to target gene promoters and suppressing Sp1 transactivation.\",\n      \"method\": \"ChIP, immunofluorescence co-localization, nuclear matrix co-fractionation, SUMOylation assay, co-immunoprecipitation, PML RING and SBM mutants\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, co-localization, co-IP, domain mutagenesis, single lab\",\n      \"pmids\": [\"24728382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SP1 governs primordial follicle formation in mice by controlling NOTCH2 expression: SP1 directly binds the Notch2 gene promoter in pregranulosa cells; knockdown of Sp1 in somatic cells suppresses nest breakdown, oocyte apoptosis, and primordial follicle formation.\",\n      \"method\": \"Conditional knockdown (Lgr5-KI reporter mouse, FOXL2+ cell-specific knockdown), ChIP for SP1 at Notch2 promoter, renal capsule transplantation\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct Notch2 promoter binding, cell-type-specific genetic knockdown with defined phenotype, single lab\",\n      \"pmids\": [\"31282930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP1 is required for stable hematopoietic differentiation trajectories; Sp1 DNA-binding domain mutation (Sp1ΔDBD/ΔDBD) distorts cell fate decision timing during hematopoiesis without dramatically altering distal accessible chromatin patterns, indicating Sp1 chromatin binding maintains robustness of differentiation rather than directing chromatin accessibility.\",\n      \"method\": \"Sp1ΔDBD/ΔDBD knock-in ES cells, hematopoietic differentiation assay, ATAC-seq, ChIP-seq, single-cell gene expression analysis\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knock-in, multi-omics, single-cell analysis, single lab\",\n      \"pmids\": [\"31164147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIRPA phosphorylates SP1 at Thr278 via ERK activation, protecting SP1 from proteasomal degradation; stabilized SP1 binds the SLC7A3 promoter to increase arginine uptake, which in turn further stabilizes SP1 in an ERK-independent manner, forming a 'SP1 stabilization circle' that promotes osteosarcoma metastasis.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation site mutagenesis (T278), proteasome inhibitor, ChIP for SP1 at SLC7A3 promoter, ERK inhibitor, xenograft model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-site mutagenesis, ChIP, pharmacological and genetic approaches, single lab\",\n      \"pmids\": [\"37769797\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SP1 is a sequence-specific transcription factor whose three C-terminal Cys2-His2 zinc fingers bind GC-box DNA elements; it assembles into tetramers that mediate transcriptional synergy via DNA looping, and its activity is extensively regulated by post-translational modifications—including phosphorylation (by PKA, ERK2, cyclin A-CDK, CDK1, JNK1, ATM), sumoylation (at K16 and K683), O-GlcNAcylation, ubiquitination (via RNF4 as E3 ligase), deubiquitination (via USP39, ZRANB1), and caspase cleavage (at D183)—that control its DNA-binding activity, protein stability, subcellular localization, and interactions with co-regulators including Rb, STAT1, ERα/β, SIRT6, Hsp90, Pin1, PML, and TRRAP-HAT complexes, thereby integrating diverse signaling inputs to regulate transcription of hundreds of target genes in processes ranging from cell cycle progression and apoptosis to differentiation and the DNA damage response.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SP1 is a sequence-specific transcription factor that activates RNA polymerase II transcription through GC-box DNA elements bound by its C-terminal Zn(II) fingers, with separate domains controlling DNA-binding affinity and transactivation [#0]. It assembles into stacked tetramers at DNA loop junctures, enabling long-range transcriptional synergism between distal and proximal GC boxes [#1], and cooperates combinatorially with partner factors at adjacent sites \\u2014 STAT1 for interferon-gamma-dependent ICAM-1 activation [#5], Oct1 for U2 snRNA gene activation [#13], and the retinoblastoma protein, which potentiates SP1 transactivation in part by liberating it from a negative regulator [#2, #4, #7]. SP1 activity is countered at GC boxes by the competing repressor Sp3 [#3] and by nuclear hormone receptors ER\\u03b1/ER\\u03b2 that bind its C-terminus to redirect transcription at GC-rich promoters [#9]. SP1 function is heavily tuned by a layered post-translational code: phosphorylation by PKA, ERK2, cyclin A-CDK, CDK1, JNK1, and ATM modulates its DNA binding, stability, and chromatin residence [#6, #8, #10, #14, #16, #20]; O-GlcNAcylation blocks specific cofactor interactions [#13]; and a SUMO/ubiquitin axis governs turnover, in which SUMO modification at Lys16 recruits the E3 ligase RNF4 for proteasomal degradation while phosphorylation events (e.g. JNK1/CDK1 at Thr739) or counteracting deubiquitinases (USP39, ZRANB1) protect the protein [#15, #17, #21, #22]. Through these inputs SP1 integrates cell-cycle, stress, and signaling cues: ATM-driven SUMO/RNF4 degradation enforces senescence [#20], CDK1/Pin1-controlled phosphorylation displaces SP1 from chromosomes during mitosis to permit cell-cycle progression [#16, #29], and caspase cleavage at Asp183 yields a pro-apoptotic fragment [#18]. SP1 also directs developmental and differentiation programs \\u2014 maintaining the epithelial state via miR-200 [#25], hematopoietic differentiation robustness [#32], primordial follicle formation through Notch2 [#31], and a TRRAP-dependent neuronal microtubule program [#23] \\u2014 and is recruited by chromatin regulators including SIRT6, which binds its zinc-finger domain to repress mTOR-pathway genes [#19], and HDAC2 [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established the modular architecture of SP1, separating DNA recognition from transactivation and defining it as a bona fide Pol II activator.\",\n      \"evidence\": \"Deletion mutagenesis with E. coli-expressed fragments in an in vitro transcription assay\",\n      \"pmids\": [\"3059495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the structural basis of GC-box recognition\", \"Activation domain cofactor partners not identified\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Answered how SP1 mediates synergy between distant promoter elements by showing it tetramerizes and loops DNA.\",\n      \"evidence\": \"Conventional and scanning transmission EM of SP1-DNA complexes\",\n      \"pmids\": [\"2062845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Multimerization interface not mapped at residue level\", \"In vivo relevance of looping geometry not tested\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined how SP1 output is set at shared GC boxes by the competing repressor Sp3 and by Rb-mediated relief of an inhibitor.\",\n      \"evidence\": \"Competition/chimera reporter assays in SL2 cells; EMSA, recombinant Rb addition, and biochemical fractionation identifying Sp1-I\",\n      \"pmids\": [\"8070411\", \"8007947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the ~20 kDa Sp1-I inhibitor not fully resolved\", \"Direct vs. indirect Rb effect on SP1 DNA binding\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrated combinatorial transcriptional synergy by showing SP1 physically partners with STAT1 at contiguous sites for interferon-gamma-dependent gene activation.\",\n      \"evidence\": \"Reciprocal co-IP from primary cells, EMSA, and reporter assays at the ICAM-1 promoter\",\n      \"pmids\": [\"8530443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction surface not mapped\", \"Generality across other STAT-SP1 target genes not established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed phosphorylation can directly enhance SP1, linking PKA signaling to SP1 DNA-binding and transcriptional activity.\",\n      \"evidence\": \"In vitro kinase assay with recombinant SP1 plus PKA agonist/antagonist reporter pharmacology\",\n      \"pmids\": [\"9261118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphoacceptor residues not mapped\", \"In vivo PKA target sites not confirmed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Placed SP1 downstream of the Ras-ERK cascade, with ERK2 phosphorylation stimulating SP1 DNA binding for growth-factor-inducible transcription.\",\n      \"evidence\": \"In vitro ERK2 phosphorylation, EMSA, dephosphorylation, and MEK-inhibitor epistasis at the gastrin promoter\",\n      \"pmids\": [\"9918860\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific ERK2 sites on SP1 not identified\", \"Single-promoter context\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Explained how estrogen signaling routes through SP1, with ER\\u03b1/ER\\u03b2 binding the SP1 C-terminus and using AF-1 to activate GC-rich promoters.\",\n      \"evidence\": \"Co-IP, pull-down, chimeric ER mapping, and AF-1 deletion reporter assays\",\n      \"pmids\": [\"10681512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SP1 residues contacted by ER not mapped\", \"Endogenous target gene repertoire not defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected SP1 to cell-cycle control by showing cyclin A-CDK binds and phosphorylates SP1 at an N-terminal site to augment its DNA binding and activity.\",\n      \"evidence\": \"Co-IP, in vitro/in vivo phosphorylation, binding-site selection, and phospho-site mutagenesis reporter assays\",\n      \"pmids\": [\"11598016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact target gene programs in S phase not delineated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed inflammatory signaling downregulates SP1, with LPS-driven Ser/Thr dephosphorylation and degradation reducing SP1-dependent gene expression.\",\n      \"evidence\": \"EMSA, IP-Western, in vitro dephosphorylation, and RT-PCR in a mouse lung model\",\n      \"pmids\": [\"12089157\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphatase responsible not identified\", \"Degradation pathway not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Integrated phosphorylation, sumoylation and ubiquitination into a coordinated processing/degradation program controlling SP1 turnover.\",\n      \"evidence\": \"In vitro SUMO/ubiquitination assays, site-directed mutagenesis, pulse-chase, and kinase inhibitor studies\",\n      \"pmids\": [\"18239466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase not identified at this stage\", \"Protease for N-terminal cleavage unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated SP1 is required for HDAC-inhibitor-induced TRAIL expression and apoptosis, linking SP1 to death-ligand transcription.\",\n      \"evidence\": \"Reporter constructs, ChIP, SP1 knockdown, and SP1-knockout mouse ES cells with apoptosis assays\",\n      \"pmids\": [\"18701496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct SP1 binding element on TRAIL promoter not detailed\", \"Mechanism of HDAC-inhibitor-driven SP1 activation unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Revealed O-GlcNAcylation as a switch that blocks specific SP1 cofactor interactions, suppressing SP1-Oct1 cooperative activation.\",\n      \"evidence\": \"Co-IP, O-GlcNAc site mapping, mutagenesis, and reporter assays at the U2 snRNA gene\",\n      \"pmids\": [\"19070619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether O-GlcNAc affects other partners not tested\", \"Dynamic regulation in vivo not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed Hsp90 chaperones SP1 stability during mitosis via JNK1-mediated phosphorylation, preventing proteasomal degradation.\",\n      \"evidence\": \"Co-IP, geldanamycin treatment, shRNA knockdown, JNK1-site mutagenesis, and ubiquitination assay\",\n      \"pmids\": [\"19245816\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase not yet identified\", \"Direct vs. JNK1-dependent Hsp90 effect not separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified RNF4 as the SUMO-targeted E3 ligase for SP1 and showed mitotic JNK1 phosphorylation at Thr739 protects SP1 from degradation.\",\n      \"evidence\": \"In vitro/in vivo ubiquitination, co-IP, and Lys16/Thr739 mutagenesis with proteasome inhibition\",\n      \"pmids\": [\"21983342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-cycle stoichiometry of SUMO-to-ubiquitin handoff not quantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved how mitotic SP1 is stabilized and removed from chromosomes by showing Pin1 binds phospho-Thr739 to drive CDK1 multisite phosphorylation.\",\n      \"evidence\": \"X-ray crystallography of Pin1-pThr739 peptide, ITC, in vitro phosphorylation, ChIP, and cell-cycle analysis\",\n      \"pmids\": [\"25398907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genes regulated by chromosome-displaced SP1 during mitosis not enumerated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissected opposing SUMO paralog effects, showing SUMO2 at Lys683/Lys16 attenuates DNA binding and increases turnover while SUMO1 is positive, controlling differentiation.\",\n      \"evidence\": \"In vivo/in vitro sumoylation, site mutagenesis, EMSA, ChIP, and a Lgr5-KI reporter mouse\",\n      \"pmids\": [\"24706897\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO ligases directing paralog choice not fully defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established PML nuclear bodies as a sequestration mechanism that SUMOylates SP1 and removes it from target promoters.\",\n      \"evidence\": \"ChIP, IF co-localization, nuclear matrix co-fractionation, sumoylation assay, and PML RING/SBM mutants\",\n      \"pmids\": [\"24728382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reversibility/release from PML bodies not characterized\", \"Target gene scope not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined an SP1-dependent epithelial maintenance program by showing SP1 activates the miR-200 family, antagonized by ZEB in mesenchymal states.\",\n      \"evidence\": \"ChIP, reporter assays, EMSA, SP1 knockdown, and in vivo embryonic co-expression analysis\",\n      \"pmids\": [\"24627491\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of ZEB-mediated block on SP1 activity not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed proteolytic conversion of SP1 to a pro-apoptotic effector via caspase cleavage at Asp183 generating the apoptosis-inducing Sp1-70C fragment.\",\n      \"evidence\": \"In vitro caspase cleavage, D183A mutagenesis, and gain/loss-of-function apoptosis assays\",\n      \"pmids\": [\"29236199\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets of Sp1-70C not defined\", \"Which caspase acts in vivo not pinned down\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified SIRT6 as a deacetylase-independent repressor that binds the SP1 zinc-finger domain to restrain mTOR-pathway gene transcription.\",\n      \"evidence\": \"Domain-mapping co-IP, ChIP, reporter assays, mTOR-inhibitor rescue, and muscle-specific SIRT6 knockout mice\",\n      \"pmids\": [\"31372634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SIRT6 binding blocks SP1 without deacetylation not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed SP1 chromatin binding maintains robustness of cell-fate transitions rather than dictating chromatin accessibility during hematopoiesis.\",\n      \"evidence\": \"Sp1\\u0394DBD knock-in ES cells with hematopoietic differentiation, ATAC-seq, ChIP-seq, and single-cell expression\",\n      \"pmids\": [\"31164147\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct target genes governing fate timing not isolated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connected SP1 to ovarian development by showing it directly drives Notch2 transcription required for primordial follicle formation.\",\n      \"evidence\": \"Cell-type-specific knockdown, ChIP at the Notch2 promoter, and renal capsule transplantation in mice\",\n      \"pmids\": [\"31282930\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream control of SP1 in pregranulosa cells not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed DNA-damage signaling drives SP1 destruction via ATM-Ser101 phosphorylation triggering Lys16 SUMO and RNF4 degradation to enforce senescence.\",\n      \"evidence\": \"S101A/K16R mutagenesis, ATM and proteasome inhibitors, sumoylation assay, and senescence-marker analysis\",\n      \"pmids\": [\"34550526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SP1 target genes whose loss drives senescence not enumerated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified deubiquitinases that oppose SP1 degradation, with USP39 and ZRANB1 directly binding and stabilizing SP1 to support proliferation and cancer phenotypes.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, cycloheximide chase, knockdown/rescue, and xenografts\",\n      \"pmids\": [\"34197957\", \"34765294\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DUB site specificity on SP1 ubiquitin chains not mapped\", \"Single-lab reports for each DUB\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed SP1 in a Keap1/cullin-RING ubiquitin network, acting as both a Keap1 ubiquitination substrate and a transcriptional regulator of CUL4A.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, ChIP, siRNA knockdown, and reporter assays\",\n      \"pmids\": [\"33895141\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect Keap1-SP1 ubiquitination not fully separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated SP1 chromatin recruitment depends on TRRAP, defining a conserved SP1-driven microtubule-dynamics program in neurons.\",\n      \"evidence\": \"ChIP-seq in conditional Trrap knockout mice, multi-omics, and Stathmin3/4 rescue\",\n      \"pmids\": [\"33594975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRRAP acts via SP1 acetylation or recruitment not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed SP1-stabilizing feedforward circuits in cancer, including SIRPA-ERK-Thr278 phosphorylation/SLC7A3 arginine uptake and HDAC2-mediated SP1 acetylation controlling macrophage polarization.\",\n      \"evidence\": \"Phospho-site mutagenesis, ChIP, ERK/proteasome inhibitors, and multiple murine tumor models\",\n      \"pmids\": [\"37769797\", \"37205635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetylation sites on SP1 modified by HDAC2 not mapped\", \"Generality of the SP1 stabilization circuit beyond osteosarcoma untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the dozens of competing post-translational inputs are quantitatively integrated to set context-specific SP1 target-gene selection remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking PTM combinations to specific gene programs\", \"Structural basis of cofactor selection at GC boxes incomplete\", \"Genome-wide SP1 target maps across signaling states not integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3, 5, 23]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 10, 32]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 4, 19, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 16, 30]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [16, 23, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 14, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [18, 27, 28]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [25, 31, 32]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [15, 17, 21]}\n    ],\n    \"complexes\": [\"PML nuclear bodies\"],\n    \"partners\": [\"RB1\", \"STAT1\", \"ESR1\", \"RNF4\", \"PIN1\", \"SIRT6\", \"PML\", \"TRRAP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}